You have access
Improved Survival of Patients With Chronic Lymphocytic Leukemia Between 1998-2022, Including the Era of Target Therapies With BCL2 and BTK Inhibitors
TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, SIVAM GAZIT, TAL PATALON and LIOR ROKACH
Anticancer Research May 2024, 44 (5) 2109-2115; DOI: https://doi.org/10.21873/anticanres.17016
